1887

Abstract

The interplay among human gut microbiota (GM) composition, osteoarthritis (OA) and OA-related medication use has been extensively discussed. However, to date, there has been no exploration of the genetic correlation among these three factors.

The potential causal link between GM and OA), and whether medications influence this relationship, remains unclear.

We utilized bidirectional Mendelian randomization (MR) to explore the genetic associations between GM and OA. We leveraged genome-wide association study (GWAS) summary statistics from the MiBioGen and GO consortia, which provided data on GM taxa and OA cases, respectively. We identified outlier single-nucleotide polymorphisms using radial-MR and assessed causal associations using inverse variance weighting (IVW), weighted median and MR-Egger methods. Robust outcomes, consistent across these methods, were reported. We addressed potential biases through tests for horizontal pleiotropy and heterogeneity, supplemented by the Mendelian randomization pleiotropy residual sum and outlier method. Multivariable MR techniques were applied to adjust for OA medication use using UK Biobank data.

IVW estimates revealed a significant increase in hip OA risk for and (brachy group) [odds ratio (OR): 1.09, 95% confidence interval (CI): 1.04–1.15, =7.82E-04; OR: 1.09, 95% CI: 1.03–1.16, =4.67E-03, respectively]. Conversely, , and exhibited protective effects (OR: 0.88, =2.14E-02; OR: 0.88, =3.33E-02; 0.91, =4.29E-02). increased the risk of knee OA (OR=1.15, 95% CI: 1.07–1.25, =4.06E-04), while decreased it (OR=0.94, 95% CI: 0.88–1.00, =4.26E-02). No significant heterogeneity or horizontal pleiotropy was observed in the results. Even after accounting for the potential confounding effect of medication, the results remained consistent. No reverse causation was detected.

Our MR study reveals gut microbiome links to OA risk. Associations hold after adjusting for medication, indicating a potential causal connection between GM and OA.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001920
2024-10-16
2024-11-05
Loading full text...

Full text loading...

References

  1. Cross M, Smith E, Hoy D, Nolte S, Ackerman I et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73:1323–1330 [View Article] [PubMed]
    [Google Scholar]
  2. Barbour KE, Helmick CG, Theis KA, Murphy LB, Hootman JM et al. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation--united states, 2010-2012. MMWR Morb Mortal Wkly Rep 2013; 62:869–873
    [Google Scholar]
  3. Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392:1859–1922 [View Article]
    [Google Scholar]
  4. Zhao X, Shah D, Gandhi K, Wei W, Dwibedi N et al. Clinical, humanistic, and economic burden of osteoarthritis among noninstitutionalized adults in the United States. Osteoarthritis Cartilage 2019; 27:1618–1626 [View Article]
    [Google Scholar]
  5. Frühbeck G, Kiortsis DN, Catalán V. Precision medicine: diagnosis and management of obesity. Lancet Diabetes Endocrinol 2018; 6:164–166 [View Article]
    [Google Scholar]
  6. Biver E, Berenbaum F, Valdes AM, Araujo de Carvalho I, Bindels LB et al. Gut microbiota and osteoarthritis management: an expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Res Rev 2019; 55:100946 [View Article] [PubMed]
    [Google Scholar]
  7. Berenbaum F. Deep phenotyping of osteoarthritis: a step forward. Ann Rheum Dis 2019; 78:3–5 [View Article] [PubMed]
    [Google Scholar]
  8. Hao X, Shang X, Liu J, Chi R, Zhang J et al. The gut microbiota in osteoarthritis: where do we stand and what can we do?. Arthritis Res Ther 2021; 23:42 [View Article] [PubMed]
    [Google Scholar]
  9. Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci 2019; 76:473–493 [View Article] [PubMed]
    [Google Scholar]
  10. Collins KH, Paul HA, Reimer RA, Seerattan RA, Hart DA et al. Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: studies in a rat model. Osteoarthritis Cartilage 2015; 23:1989–1998 [View Article]
    [Google Scholar]
  11. Zhang J, Zhang J, Wang R. Gut microbiota modulates drug pharmacokinetics. Drug Metab Rev 2018; 50:357–368 [View Article] [PubMed]
    [Google Scholar]
  12. Sen P, Molinero-Perez A, O’Riordan KJ, McCafferty CP, O’Halloran KD et al. Microbiota and sleep: awakening the gut feeling. Trends Mol Med 2021; 27:935–945 [View Article] [PubMed]
    [Google Scholar]
  13. Zhang SL, Bai L, Goel N, Bailey A, Jang CJ et al. Human and rat gut microbiome composition is maintained following sleep restriction. Proc Natl Acad Sci U S A 2017; 114:E1564–E1571 [View Article] [PubMed]
    [Google Scholar]
  14. Matenchuk BA, Mandhane PJ, Kozyrskyj AL. Sleep, circadian rhythm, and gut microbiota. Sleep Med Rev 2020; 53:101340 [View Article] [PubMed]
    [Google Scholar]
  15. Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA 2017; 318:1925–1926 [View Article] [PubMed]
    [Google Scholar]
  16. Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet 2021; 53:156–165 [View Article] [PubMed]
    [Google Scholar]
  17. MiBioGen consortium MiBioGen; 2021 https://mibiogen.gcc.rug.nl/
  18. Boer CG, Hatzikotoulas K, Southam L, Stefánsdóttir L, Zhang Y et al. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations. Cell 2021; 184:4784–4818 [View Article] [PubMed]
    [Google Scholar]
  19. Wu Y, Byrne EM, Zheng Z, Kemper KE, Yengo L et al. Genome-wide association study of medication-use and associated disease in the UK Biobank. Nat Commun 2019; 10:1891 [View Article]
    [Google Scholar]
  20. Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet 2019; 51:600–605 [View Article] [PubMed]
    [Google Scholar]
  21. Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013; 37:658–665 [View Article] [PubMed]
    [Google Scholar]
  22. Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 2016; 35:1880–1906 [View Article] [PubMed]
    [Google Scholar]
  23. Chen H-W, Zhou R, Cao B-F, Liu K, Zhong Q et al. The predictive, preventive, and personalized medicine of insomnia: gut microbiota and inflammation. EPMA J 2023; 14:571–583 [View Article] [PubMed]
    [Google Scholar]
  24. Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N et al. A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 2017; 36:1783–1802 [View Article] [PubMed]
    [Google Scholar]
  25. Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol 2017; 46:1985–1998 [View Article] [PubMed]
    [Google Scholar]
  26. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40:304–314 [View Article] [PubMed]
    [Google Scholar]
  27. Bowden J, Spiller W, Del Greco M F, Sheehan N, Thompson J et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression. Int J Epidemiol 2018; 47:1264–1278 [View Article] [PubMed]
    [Google Scholar]
  28. Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol 2021; 36:465–478 [View Article] [PubMed]
    [Google Scholar]
  29. Burgess S, Thompson DJ, Rees JMB, Day FR, Perry JR et al. Dissecting causal pathways using Mendelian randomization with summarized genetic data: application to age at menarche and risk of breast cancer. Genetics 2017; 207:481–487 [View Article]
    [Google Scholar]
  30. Reitmeier S, Kiessling S, Clavel T, List M, Almeida EL et al. Arrhythmic gut microbiome signatures predict risk of type 2 diabetes. Cell Host & Microbe 2020; 28:258–272 [View Article]
    [Google Scholar]
  31. Segers A, Depoortere I. Circadian clocks in the digestive system. Nat Rev Gastroenterol Hepatol 2021; 18:239–251 [View Article]
    [Google Scholar]
  32. Wang Z, Wang Z, Lu T, Chen W, Yan W et al. The microbiota-gut-brain axis in sleep disorders. Sleep Med Rev 2022; 65:101691 [View Article] [PubMed]
    [Google Scholar]
  33. Wei J, Yang Z, Li J, Zhang Y, Zhang W et al. Association between gut microbiome-related metabolites and symptomatic hand osteoarthritis in two independent cohorts. EBioMedicine 2023; 98:104892 [View Article] [PubMed]
    [Google Scholar]
  34. Boer CG, Radjabzadeh D, Medina-Gomez C, Garmaeva S, Schiphof D et al. Intestinal microbiome composition and its relation to joint pain and inflammation. Nat Commun 2019; 10:4881 [View Article] [PubMed]
    [Google Scholar]
  35. Wei J, Zhang Y, Hunter D, Zeng C, Lei G. The gut microbiome-joint axis in osteoarthritis. Sci Bull 2023; 68:759–762 [View Article] [PubMed]
    [Google Scholar]
  36. Dunn CM, Velasco C, Rivas A, Andrews M, Garman C et al. Identification of cartilage microbial DNA signatures and associations with knee and hip osteoarthritis. Arthritis Rheumatol 2020; 72:1111–1122 [View Article] [PubMed]
    [Google Scholar]
  37. Huang Z, Chen J, Li B, Zeng B, Chou C-H et al. Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice. Ann Rheum Dis 2020; 79:646–656 [View Article] [PubMed]
    [Google Scholar]
  38. Guan Z, Jia J, Zhang C, Sun T, Zhang W et al. Gut microbiome dysbiosis alleviates the progression of osteoarthritis in mice. Clin Sci 2020; 134:3159–3174 [View Article]
    [Google Scholar]
  39. Chen J, Wang A, Wang Q. Dysbiosis of the gut microbiome is a risk factor for osteoarthritis in older female adults: a case control study. BMC Bioinform 2021; 22:299 [View Article] [PubMed]
    [Google Scholar]
  40. Lei M, Guo C, Wang D, Zhang C, Hua L. The effect of probiotic Lactobacillus casei shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial. Benef Microbes 2017; 8:697–703 [View Article] [PubMed]
    [Google Scholar]
  41. So J-S, Song M-K, Kwon H-K, Lee C-G, Chae C-S et al. Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis. Life Sci 2011; 88:358–366 [View Article] [PubMed]
    [Google Scholar]
  42. Sim B-Y, Choi H-J, Kim M-G, Jeong D-G, Lee D-G et al. Effects of ID-CBT5101 in preventing and alleviating osteoarthritis symptoms in a monosodium iodoacetate-induced rat model. J Microbiol Biotechnol 2018; 28:1199–1208 [View Article] [PubMed]
    [Google Scholar]
  43. Kwon JY, Lee SH, Jhun J, Choi J, Jung K et al. The combination of probiotic complex, rosavin, and zinc improves pain and cartilage destruction in an osteoarthritis rat model. J Med Food 2018; 21:364–371 [View Article] [PubMed]
    [Google Scholar]
  44. Shang Q, Yin Y, Zhu L, Li G, Yu G et al. Degradation of chondroitin sulfate by the gut microbiota of Chinese individuals. Int J Biol Macromol 2016; 86:112–118 [View Article] [PubMed]
    [Google Scholar]
  45. Stebbings S, Gray A, Schneiders AG, Sansom A. A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee. BMC Complement Altern Med 2017; 17:416 [View Article] [PubMed]
    [Google Scholar]
  46. Banerjee S, Sindberg G, Wang F, Meng J, Sharma U et al. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol 2016; 9:1418–1428 [View Article] [PubMed]
    [Google Scholar]
  47. Neroni B, Evangelisti M, Radocchia G, Di Nardo G, Pantanella F et al. Relationship between sleep disorders and gut dysbiosis: what affects what?. Sleep Med 2021; 87:1–7 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001920
Loading
/content/journal/jmm/10.1099/jmm.0.001920
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error